Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Sphingosine 1-Phosphate Receptor Modulators in Multiple Sclerosis.
Aquatic training in MS: neurotherapeutic impact upon quality of life.
A review of current and emerging therapeutic strategies in multiple sclerosis.
Combination of robot-assisted and conventional body-weight-supported treadmill training improves gait in persons with multiple sclerosis: a pilot study.
Impact of delayed diagnosis and treatment in clinically isolated syndrome and multiple sclerosis.
Work-related problems in multiple sclerosis: a literature review on its associates and determinants.
Effect of switching from intramuscular interferon β-1a to oral fingolimod on time to relapse in patients with relapsing-remitting multiple sclerosis enrolled in a 1-year extension of TRANSFORMS.
Assessment of immune functions and MRI disease activity in relapsing-remitting multiple sclerosis patients switching from natalizumab to fingolimod (ToFingo-Successor).
So many progenitors, so little myelin.
Induction chemotherapy, extrapleural pneumonectomy, and adjuvant radiotherapy for malignant pleural mesothelioma: experience of Guy's and St Thomas' hospitals.
Exploring the potential of public proteomics data.
IL-17 induces MIP-1α expression in primary mouse astrocytes via TRPC channel.
Environmental factors and their regulation of immunity in multiple sclerosis.
Treatment of Acute Relapses in Multiple Sclerosis.
SIRT1 activating compounds reduce oxidative stress and prevent cell death in neuronal cells.
Estrogen inhibits estrogen receptor(ER) α-mediated rho-kinase expression in experimental autoimmune encephalomyelitis rats.
Clinical utility of glatiramer acetate in the management of relapse frequency in multiple sclerosis.
Notch Signaling Regulates T Cell Accumulation and Function in the Central Nervous System during Experimental Autoimmune Encephalomyelitis.
The genetics of multiple sclerosis: review of current and emerging candidates.
Recurrent Varicella following Steroids and Fingolimod in a Multiple Sclerosis Patient.
Anti-CD79 Antibody Induces B Cell Anergy That Protects against Autoimmunity.
Adverse events during the titration phase of interferon-beta in remitting-relapsing multiple sclerosis are not predicted by body mass index nor by pharmacodynamic biomarkers.
Prolactin Is Not Required for the Development of Severe Chronic Experimental Autoimmune Encephalomyelitis.
Neuroinflammation: The role and consequences.
New Approaches in the Design and Development of Cannabinoid Receptor Ligands: Multifunctional and Bivalent Compounds.

Pages